PEN · Healthcare
Penumbra Inc
39/100
Smart-money confidence1 of 3 sources positive
Weak — few signals
No standout activity across the feeds we track.
Hedge funds
52
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s. ·
how the score works
Market cap
$12.9B
Industry
Medical Devices
Sector
Healthcare
Exchange
NYSE
About PENUMBRA INC
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and…
Who's behind the signal
Every informed buyer we can see on PEN, across all three feeds.
Hedge funds · 9
Soros Fund Management (Soros)
New position
Tudor Investment (Paul Tudor Jones)
New position
Millennium Management (Englander)
Increased +62%
D.E. Shaw & Co
Increased +2584%
Gotham Asset Mgmt (Greenblatt)
Increased +1103%
Bridgewater Associates (Dalio)
Increased +743%
+3 more in the full breakdown below ↓
Congress · 0
No congressional trades on record.
Insiders
No significant Form 4 insider activity in the window.
Not a model pick — but on our radar.
PENUMBRA INC isn't in the top-10 model right now, but 9 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
9
Investors
2
New positions
4
Increasing
3
Decreasing
0
Unchanged
Price History
Loading price data...
Return:
High:
Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.5×
% of portfolio
1.2%
Position change
NEW
1.2% of Soros Fund Management's portfolio
Trust weight: 1.2×
% of portfolio
0.7%
Position change
NEW
0.7% of Tudor Investment's portfolio
Trust weight: 1.0×
% of portfolio
0.3%
Position change
+62%
0.3% of Millennium Management's portfolio
Trust weight: 1.0×
% of portfolio
0.1%
Position change
+2584%
0.1% of D.E. Shaw & Co's portfolio
Trust weight: 1.1×
% of portfolio
0.0%
Position change
+1103%
0.0% of Gotham Asset Mgmt's portfolio
Trust weight: 1.3×
% of portfolio
0.0%
Position change
+743%
0.0% of Bridgewater Associates's portfolio
Trust weight: 1.4×
% of portfolio
0.3%
Position change
−4%
0.3% of Baillie Gifford & Co's portfolio
Trust weight: 1.0×
% of portfolio
0.1%
Position change
−80%
0.1% of Citadel Advisors's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
−58%
0.0% of AQR Capital Management's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to PENUMBRA INC
No insider trades found in the last 90 days
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell PENUMBRA INC or any security.
订阅每周更新
我们每周会把巴菲特、达利欧、阿克曼以及另外 47 位传奇投资人正在买入的股票发送给你 — 免费，直接来自他们的 SEC 申报文件。
永久免费 · 无垃圾邮件 · 随时退订